Phase 3 Readout~month

Phase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Genera

Indication
Myasthaenia Gravis

Other upcoming events for RNAC

Phase 2 StartPhase 2 Start: A Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Genera — RNAC Phase 3 Readout | BioSniper